Polycomb and lung cancer: When the dosage makes the (kind of) poison

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The Polycomb transcriptional repressors regulate normal tissue homeostasis and their function is often hijacked during oncogenesis. We recently uncovered the Polycomb repressive complex-2 (PRC2) genes Ezh2 and Eed as oncogenotype-dependent cancer genes. Notably, within the same oncogenotype, PRC2 dosage modulates lung tumor homeostasis and critically impacts non-tumor tissue function.

Cite

CITATION STYLE

APA

Gargiulo, G., Citterio, E., & Serresi, M. (2016). Polycomb and lung cancer: When the dosage makes the (kind of) poison. Molecular and Cellular Oncology, 3(3). https://doi.org/10.1080/23723556.2016.1152345

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free